Target intelligence / Profile preview

MicroRNA-467a-3p (miR-467a-3p)

Target
miR-467a-3p
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA, Other
01

Overview

MicroRNA-467a-3p is a small, single-stranded, non-coding RNA molecule that functions as a post-transcriptional regulator of gene expression by binding to specific messenger RNAs (mRNAs) and inhibiting their translation or promoting their degradation[7][1]. It has been shown to regulate the **stemness** (self-renewal capacity) and **myogenesis** (muscle cell formation) of satellite cells, which are key for muscle maintenance and regeneration. Dysregulation of miR-467a-3p can contribute to conditions like sarcopenia, an age-associated disease characterized by muscle loss and functional decline. Therapeutic strategies targeting miR-467a-3p, such as antagomiRs and miRNA mimics, are under exploration for influencing satellite cell behavior and for potential use in muscle-degenerative diseases[1][3][5].

Other names
miR-467a-3pmmu-miR-467a-3p (mouse ortholog designation)
02

Mechanism of action

AntagomiR-467a-3p: Competitive inhibition of endogenous miR-467a-3p, preventing it from binding its target mRNAs, thereby upregulating target gene expression[1]. miR-467a-3p mimic: Introduction of synthetic miRNA to mimic the function of endogenous miR-467a-3p, increasing suppression of target mRNAs[3][5].

03

Biological functions

Regulation of cell proliferationRegulation of cell differentiationStem cell maintenance (stemness)Myogenesis
04

Disease associations

SarcopeniaPotentially other diseases involving cell differentiation and muscle regeneration
05

Safety considerations

Off-target effects common to miRNA-based therapies, including possible dysregulation of non-intended pathways (inferred from general miRNA therapeutic concerns)[7][9]Delivery challenges for miRNA inhibitors or mimics to targeted tissues (inferred from general miRNA delivery literature)[1]Immunogenicity or toxicity of synthetic miRNA therapeutics[1]
06

Interacting drugs

AntagomiR-467a-3p (synthetic antimiR inhibitor)[1]

1 more in the full profile.

07

Biomarkers

Changes in miR-467a-3p levels as a potential biomarker for sarcopenia progression and response to therapy[1]

Beyond the preview

Go deeper on MicroRNA-467a-3p (miR-467a-3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-467a-3p (miR-467a-3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call